Status:
COMPLETED
Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly
Lead Sponsor:
Chi-Chang Huang
Collaborating Sponsors:
Bened Biomedical Co., Ltd.
Conditions:
Elderly
Muscle Loss
Eligibility:
All Genders
65-85 years
Phase:
NA
Brief Summary
This study refers to the supplementation of PS23 in human experiments to help the elderly maintain muscle mass, delay muscle loss, promote physical activity, and delay the occurrence of disability and...
Detailed Description
Taiwan has become an aging society in recent years. There are important issues to attenuate aging and activate the potential capacity of elderly population. The physical function of middle-aged and ol...
Eligibility Criteria
Inclusion
- age between 65 and 85 years old
Exclusion
- Have taken antibiotics within one month or are receiving antibiotic treatment
- Have used probiotic products in powder, capsule or tablet form within two weeks (except for yogurt, yogurt, Yakut and other related foods)
- People allergic to lactic acid bacteria products
- Patients diagnosed with stroke or hypertension (systolic blood pressure greater than 139, diastolic blood pressure greater than 89)
- Exclusion of limbs and hips that have been replaced with artificial joints
- Persons with incapacity/insufficient decision-making ability
- Who has been determines that it is not suitable to participate in the research.
Key Trial Info
Start Date :
August 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT06062472
Start Date
August 8 2023
End Date
December 31 2023
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan Sport University
Taoyuan District, Taiwan, 333